← Home / CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
Stock Analysis
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
CLOV
CLOV · Market data
4.17 -3.92%
Track CLOV in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when CLOV price is:
52W Range Position
67%
LOWMIDHIGH
Trend
Mixed
Momentum
Neutral
Updated: 2026-08-02 22:29 UTC
WOI Investment Thesis
Mixed
Confirmation improves above 4.31. Holding above 3.34 keeps the current thesis intact.
⚖️
✓
Fundamentals
Strong / Improving
✓
Price Structure
Mixed
•
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
3.34
↗
Break Above
Confirmation improves above resistance.
4.31
🎯
Next Objective
Pattern-derived target if setup continues.
—
×
Thesis Break
Scenario weakens below invalidation.
Below 3.34
Recent Company Events
SEC VERIFIED
Latest material filings
JUN
16
●
Management / Board
MEDIUM
CLOV board and management update
On June 15, 2026, Brady Priest notified Clover Health Investments, Corp.
8-K Filing • SEC EDGAR
MAY
6
●
Financial Results
HIGH
Clover Health Reports First Quarter 2026 Results
(Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today reported financial results for the first quarter 2026.
8-K Filing • SEC EDGAR
What's Driving CLOV?
📈 Technical recovery is improving
Momentum is Neutral. Watch 4.31 for confirmation and 3.34 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
losing 3.34 would weaken the current structure.
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
▲
No confirmed breakout yet. Watch the next level and momentum behavior.
Pattern
Triangle Compression
State
Forming
Compression
42%
RSI(14)
41.2
◎
How to read this setup
From a roadmap perspective, the setup is boxed by support near 3.34 and resistance around 4.31. Clearing resistance would strengthen the constructive case, while a failure through support would damage the present setup.
Price Chart
CLOV — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-07-31
Loss
Earnings not meaningful
Earnings are negative or not useful, so sales, book value and cash-flow metrics matter more.
Market Cap
$2.2B
Company size
EV
$2.0B
Debt-adjusted value
P/E
-39.0
Not meaningful
P/S
1.0
Low sales multiple
P/B
6.5
Balanced
EV/Sales
0.9
Low sales multiple
EV/EBIT
-34.3
Not meaningful
P/FCF
40.7
Premium
FCF Yield
2.46%
Cash return
Source: SEC TTM data via WOI valuation cache Not financial advice
Business Lens
Improving financial execution
Revenue and profitability remain supportive, while cash flow and balance sheet quality require monitoring.
↗
Revenue Growth
Strong
●
Profitability
Improving
≈
Cash Flow
Healthy
⚖
Balance Sheet
Manageable
💵 Revenue
749.19M
↗ Strong
📈 Net Income
27.33M
↗ Improving
🧮 EPS (Basic)
0.05
↗ Improving
CLOVER HEALTH INVESTMENTS, CORP. /DE
Related Opportunities